PsychedelicStockWatch

Overall, we still see the #psychedelics sector spinning its wheels. Market conditions remain poisonous for most of these stocks. Corrupt governments (dealing with out-of-control mental health crises) remain lethargic in pushing through necessary legal reforms. $PSYK $PSIL

Then there is $MNMD... microdose.buzz/news/mindmed-f… I'm still holding most of my shares here, but if the ship doesn't get righted soon, will have to review the situation. $MMED $MMQ

I'm disappointed (but not totally surprised) that the Field Trip/Reunion Neuroscience hasn't been accretive for shareholders. I didn't see this as a good time for #psychedelics entities to be making themselves smaller.

Been really busy these past few weeks with other projects, but thought I would check in with a quick update. Just noticed that $GHRS is the new market cap leader in the space, edging out both $ATAI and $CMPS. $NUMI and $SEEL getting some traction lately. #psychedelicstocks

Subtitle: "Psychedelic drugs and therapy are fueling the conversations on potentially revolutionary treatment and a paradigm shift for mental health disorders." Looks like they are finally starting to get it. 👍

How the Psychedelics Industry Is Taking on the Future The mainstream media is finally starting to catch up to the content we were already producing in early 2020. 😉 #psychedelics #psychedelicstocks $PSYK $PSIL #shroomstocks newsweek.com/how-psychedeli…

Really interesting to see what happens tomorrow if the bankers schedule an "up day" in markets with their algorithms. 😉

$DRUG powers higher today (+72.80%) despite the strong selloff in markets. Another mega-volume day: 82+ million. More of a "tug-of-war" day for $MNMD: volume (on the NASDAQ) 57+ million, but relatively unchanged in price (-1.50%). #psychedelicstocks $MMED #shroomstocks

$DRUG (+169%, vol: ~50 million) and $MNMD (+7.87%, vol: ~33 million) resume their uptrend and heavy trading. #psychedelicstocks $MMED #shroomstocks

@SteveWes4 It means "who knows what we're going to see on Monday?" 😉

What does this mean for $DRUG? Trending upwards? $CDR, $DRUG, $AGLE, $SMMT, $MNMD, $EDBL, $ACON, $HILS, $CRIS, $GNS, $LPTH, $ALLR, $SKFG, $BMXI, $WEBR, $GTII, $ENDP, $PSTV, $GNS, $AVYA, $NEPT, $INDO

An unfortunate day to follow up yesterday's general bounce for the sector and insane feeding frenzies on $MNMD and $DRUG. Due to technical imbalances in the options market, this is creating a strong downward bias across equity classes and global markets. #psychedelicstocks

We saw elevated volume (and smaller bumps in share price) for several other players across the #psychedelics space today. It will be very interesting to see what happens when markets open on Friday. 😉

The OTHER feeding frenzy on the day was $DRUG. An even bigger bounce (+135.87%) on even heavier volume, by dollar value: 119 million shares. Obviously, $DRUG (and many others) were way overdue for such a corrective bounce. #psychedelicstocks #shroomstocks $PSYK $PSIL

@iamacalderon Lol! I've been really busy this week with other projects, so wasn't even looking at markets until after hours -- when I heard about $MNMD.

A little slow getting today's main market action, but the numbers speak for themselves. $MNMD +36.18% NASDAQ volume: 224+ million shares. Calling that "a feeding frenzy" would be a bit of an understatement (lol). #psychedelicstocks #psychedelics #shroomstocks $MMED $MMQ

@Dolphins19845 What's really crazy is that a fairly big chunk of this mega-volume came right at the open. I'm surprised the stock didn't pop even higher with that amount of upward push.

@PsychStockWatch Unless we have some really “rich” retail…….

Sitting up another 11.75% in the after-hours market.

What sparked this sudden stampede is (apparently) this... Mind Medicine Stock Is Surging. A Student Who Made $110 Million Trading Bed Bath & Beyond Could Be Why finance.yahoo.com/m/dfec50a3-2df…

@unoyoya I was somewhat dismissive of #ketamine (at first) as well. But as I learn more about its efficacy and as our despicable governments drag their heels on opening up other #psychedelics, I think all investors in #psychedelicstocks need ketamine exposure.

@PsychStockWatch Sure, ATAI is a safer biotech. But if we discount pseudo psychedelics like ketamine / MDMA, when the smoke clears, I see a farming industry with natural psilocybin. In a decade, maybe a couple novel psychedelics. Investors are in denial. Just waiting for them to wake up.

atai Life Sciences Reports Second Quarter 2022 Financial Results & Business Update $ATAI announces a new $175 million loan facility, streamlines operations, and now has total cash/financing of $487 million. #psychedelicstocks $CMPS $PSYK psychedelicstockwatch.com/psychedelic-st…